91 related articles for article (PubMed ID: 20369480)
21. Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
Signoroni S; Frattini M; Negri T; Pastore E; Tamborini E; Casieri P; Orsenigo M; Da Riva L; Radice P; Sala P; Gronchi A; Bertario L; Pierotti MA; Pilotti S
Clin Cancer Res; 2007 Sep; 13(17):5034-40. PubMed ID: 17785554
[TBL] [Abstract][Full Text] [Related]
22. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
23. Cytokines associated with the pathophysiology of aggressive fibromatosis.
Mills BG; Frausto A; Brien E
J Orthop Res; 2000 Jul; 18(4):655-62. PubMed ID: 11052503
[TBL] [Abstract][Full Text] [Related]
24. [Significance of beta-catenin and Cyclin D1 express in glioma].
Zhang ZQ; Chen HQ; Chen YH; Cheng XF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):1010-2. PubMed ID: 19900369
[TBL] [Abstract][Full Text] [Related]
25. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
26. A retroperitoneal fibrous lesion with a specific CTNNB1 mutation but absence of beta-catenin immunodetection: benign process or unusual desmoid-type fibromatosis?
Rouleau C; Vernhet H; Marty M; Hostein I; Alric P; Coindre JM
Pathology; 2011 Dec; 43(7):751-3. PubMed ID: 22124265
[No Abstract] [Full Text] [Related]
27. Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases.
Huang PW; Tzen CY
Pathology; 2010 Feb; 42(2):147-50. PubMed ID: 20085516
[TBL] [Abstract][Full Text] [Related]
28. Pediatric aggressive fibromatosis of the head and neck: a 20-year retrospective review.
Sharma A; Ngan BY; Sándor GK; Campisi P; Forte V
J Pediatr Surg; 2008 Sep; 43(9):1596-604. PubMed ID: 18778992
[TBL] [Abstract][Full Text] [Related]
29. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
[TBL] [Abstract][Full Text] [Related]
30. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
Bahrami A; Folpe AL
Am J Surg Pathol; 2010 Oct; 34(10):1504-13. PubMed ID: 20829680
[TBL] [Abstract][Full Text] [Related]
31. [Aggressive fibromatoses].
Döhler JR; Hamelmann H; Lasson U
Chirurg; 1984 Mar; 55(3):174-8. PubMed ID: 6714018
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
Salas S; Chibon F; Noguchi T; Terrier P; Ranchere-Vince D; Lagarde P; Benard J; Forget S; Blanchard C; Dômont J; Bonvalot S; Guillou L; Leroux A; Mechine-Neuville A; Schöffski P; Laë M; Collin F; Verola O; Carbonnelle A; Vescovo L; Bui B; Brouste V; Sobol H; Aurias A; Coindre JM
Genes Chromosomes Cancer; 2010 Jun; 49(6):560-8. PubMed ID: 20232483
[TBL] [Abstract][Full Text] [Related]
33. A gene expression signature that distinguishes desmoid tumours from nodular fasciitis.
Bacac M; Migliavacca E; Stehle JC; McKee T; Delorenzi M; Coindre JM; Guillou L; Stamenkovic I
J Pathol; 2006 Mar; 208(4):543-53. PubMed ID: 16440290
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.
López-Knowles E; Zardawi SJ; McNeil CM; Millar EK; Crea P; Musgrove EA; Sutherland RL; O'Toole SA
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):301-9. PubMed ID: 20056651
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of diffusion-weighted imaging for differentiating between desmoid tumors and malignant soft tissue tumors.
Oka K; Yakushiji T; Sato H; Fujimoto T; Hirai T; Yamashita Y; Mizuta H
J Magn Reson Imaging; 2011 Jan; 33(1):189-93. PubMed ID: 21182138
[TBL] [Abstract][Full Text] [Related]
37. Expression of E-cadherin, beta-catenin and Ki-67 antigen and their reciprocal correlations in fibrosarcomas of soft tissues in dogs.
Nowak M; Madej JA; Dziegiel P
In Vivo; 2007; 21(5):751-6. PubMed ID: 18019408
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature.
Carlson JW; Fletcher CD
Histopathology; 2007 Oct; 51(4):509-14. PubMed ID: 17711447
[TBL] [Abstract][Full Text] [Related]
39. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
Oshiro Y; Fukuda T; Tsuneyoshi M
Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
[TBL] [Abstract][Full Text] [Related]
40. [The expression of beta-catenin and its significance in leukemia cells].
Mai YJ; Qiu LG; Li ZJ; Yu Z; Li CH; Wang YF; Wang GR; Li Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):541-4. PubMed ID: 18078131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
